EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Anterior gradient‐2 regulates cell communication by coordinating cytokine–chemokine signaling and immune infiltration in breast cancer

Shichao Zhang iD, Qin Liu, Yimei Wei, Yu Xiong, Yan Gu, Ya Huang, Fuzhou Tang iD, Yan Ouyang

Cancer Science · 2023

DOI: 10.1111/cas.15775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Shichao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Pr…. Hauptthemen laut MEDLINE: Oncogene Proteins, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Excellent Young Talents Plan of Guizhou Medical University, National Natural Science Foundation of China, the Science and Technology Foundation of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anterior gradient‐2 (AGR2) is crucial to breast cancer progression. However, its role in the tumor immune microenvironment remains unclear. RNA sequencing expression profiles and associated clinical information were downloaded from The Cancer Genome Atlas and Gene Expression Omnibus databases, respectively. The AGR2 expression patterns were verified using clinical samples of breast cancer. Based on single‐cell transcriptomic data, AGR2 expression patterns were identified and cell communication analysis was carried out. Furthermore, the roles of AGR2 in breast tumor progression were explored by a series of functional experiments. We found that DNA methylation was an important mechanism for regulating the expression patterns of AGR2. Patients with AGR2 low expression displayed an immune “hot” and immunosuppressive phenotype characterized by high abundance of tumor immune cell infiltration and increased enrichment scores for transforming growth factor‐β (TGF‐β) and epithelial–mesenchymal transition pathways, whereas patients with AGR2 high expression showed an opposite immunologic feature with a lack of immune cell infiltration, suggestive of an immune “cold” and desert phenotype. Moreover, single‐cell analysis further revealed that AGR2 in malignant cells alters cell–cell interactions by coordinating cytokine–chemokine signaling and immune infiltration. Notably, two immunotherapy cohorts revealed that AGR2‐coexpressed genes could serve as prognostic indicators of patient survival. In conclusion, AGR2 could promote breast cancer progression by affecting the tumor immune microenvironment. Patients with AGR2 low expression could be suitable for combination treatment with immune checkpoint inhibitor agents and TGF‐β blockers. Therefore, this study provides a theoretical foundation for developing a strategy for personalized immunotherapy to patients with breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncogene ProteinsNeoplasmsMucoproteinsCytokinesCell CommunicationChemokinesTransforming Growth Factor betaTumor Microenvironment

Stichwörter der Autor:innen

AGR2breast cancerimmunotherapysingle-cell analysistumor microenvironment

Substanzen

Oncogene ProteinsMucoproteinsCytokinesChemokinesTransforming Growth Factor beta

Autor:innen und Institutionen

  • Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, Guizhou Medical University, Guiyang, China.
  • Immune Cells and Antibody Engineering Research Center of Guizhou Province, Key Laboratory of Biology and Medical Engineering, Guizhou Medical University, Guiyang, China.

ORCID-Profile: Shichao Zhang, Fuzhou Tang

Förderung

  • Excellent Young Talents Plan of Guizhou Medical University
  • National Natural Science Foundation of China
  • the Science and Technology Foundation of Guizhou Province

Zitieren

APA

Zhang, S., Liu, Q., Wei, Y., Xiong, Y., Gu, Y., Huang, Y., Tang, F., & Ouyang, Y. (2023). Anterior gradient‐2 regulates cell communication by coordinating cytokine–chemokine signaling and immune infiltration in breast cancer. Cancer Science. https://doi.org/10.1111/cas.15775

Vancouver

Zhang S, Liu Q, Wei Y, Xiong Y, Gu Y, Huang Y, et al. Anterior gradient‐2 regulates cell communication by coordinating cytokine–chemokine signaling and immune infiltration in breast cancer. Cancer Science. 2023. doi:10.1111/cas.15775

BibTeX
@article{Zhang2023,
  author = {Zhang, Shichao and Liu, Qin and Wei, Yimei and Xiong, Yu and Gu, Yan and Huang, Ya and Tang, Fuzhou and Ouyang, Yan},
  title = {Anterior gradient‐2 regulates cell communication by coordinating cytokine–chemokine signaling and immune infiltration in breast cancer},
  journal = {Cancer Science},
  year = {2023},
  doi = {10.1111/cas.15775}
}
Kostenlos starten →